Tanaka, J., Tanaka, N., Wang, Y.-H., Mitsuhashi, K., Ryuzaki, M., Iizuka, Y., Watanabe, A., Ishiyama, M., Shinohara, A., Kazama, H., Hagiwara, S., Yoshinaga, K., Kougen, Y., Kobayashi, H., Kanno, H. and Shiseki, M. (2020) “Phase I study of cellular therapy using ex vivo expanded natural killer cells from autologous peripheral blood mononuclear cells combined with rituximab-containing chemotherapy for relapsed CD20-positive malignant lymphoma patients”, Haematologica. Pavia, Italy, 105(4), pp. e190-e193. doi: 10.3324/haematol.2019.226696.